Astria Therapeutics, Inc. - stock earnings
ATXS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -31.4 million USD | ? USD |
| 2023Q3 | -17.7 million USD | ? USD |
| 2023Q2 | -12.6 million USD | ? USD |
| 2023Q1 | -8.9 million USD | ? USD |
| 2022Q4 | -12.2 million USD | ? USD |
| 2022Q3 | -11.2 million USD | ? USD |
| 2022Q2 | -10.8 million USD | ? USD |
| 2022Q1 | -15.2 million USD | ? USD |
| 2021Q4 | -9.5 million USD | ? USD |
| 2021Q3 | -7.9 million USD | ? USD |
| 2021Q2 | -7.5 million USD | ? USD |
| 2021Q1 | -170.1 million USD | ? USD |
| 2020Q4 | -9.0 million USD | ? USD |
| 2020Q3 | -10.9 million USD | ? USD |
| 2020Q2 | -9.5 million USD | ? USD |
| 2020Q1 | -8.0 million USD | ? USD |
| 2019Q4 | -6.6 million USD | ? USD |
| 2019Q3 | -6.5 million USD | ? USD |
| 2019Q2 | -7.1 million USD | ? USD |
| 2019Q1 | -6.0 million USD | ? USD |
| 2018Q4 | -6.1 million USD | ? USD |
| 2018Q3 | -5.7 million USD | ? USD |
| 2018Q2 | -6.5 million USD | ? USD |
| 2018Q1 | -7.7 million USD | ? USD |
| 2017Q4 | -5.5 million USD | 250000 USD |
| 2017Q3 | -7.0 million USD | 250000 USD |
| 2017Q2 | -7.0 million USD | ? USD |
| 2017Q1 | -7.9 million USD | ? USD |
| 2016Q4 | -8.8 million USD | ? USD |
| 2016Q3 | -8.4 million USD | ? USD |
| 2016Q2 | -9.4 million USD | ? USD |
| 2016Q1 | -9.4 million USD | ? USD |
| 2015Q4 | -9.6 million USD | ? USD |
| 2015Q3 | -8.5 million USD | ? USD |
| 2015Q2 | -8.0 million USD | ? USD |
| 2015Q1 | -6.5 million USD | ? USD |
| 2014Q4 | -6.0 million USD | ? USD |
| 2014Q3 | -6.0 million USD | ? USD |
| 2014Q2 | -5.4 million USD | ? USD |
| 2014Q1 | -4.5 million USD | ? USD |
ATXS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -72.9 million USD | ? USD |
| 2022 | -50.2 million USD | ? USD |
| 2021 | -30.2 million USD | ? USD |
| 2020 | -37.1 million USD | ? USD |
| 2019 | -26.2 million USD | ? USD |
| 2018 | -25.9 million USD | ? USD |
| 2017 | -27.4 million USD | 500000 USD |
| 2016 | -36.1 million USD | ? USD |
| 2015 | -32.6 million USD | ? USD |
| 2014 | -21.9 million USD | ? USD |
| 2013 | -18.1 million USD | ? USD |
ATXS
Price: $9.55
52 week price:
Earnings Per Share: -2.42 USD
P/E Ratio: -7.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 121600
Market Capitalization: 593.5 million